Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$2.24B |
| 2 |
Microsoft
MSFT
|
+$2.13B |
| 3 |
Apple
AAPL
|
+$2.08B |
| 4 |
NVIDIA
NVDA
|
+$1.81B |
| 5 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.65B |
Top Sells
| 1 |
iShares China Large-Cap ETF
FXI
|
+$596M |
| 2 |
Jefferies Financial Group
JEF
|
+$403M |
| 3 |
SPDR Gold Trust
GLD
|
+$341M |
| 4 |
S&P Global
SPGI
|
+$285M |
| 5 |
CrowdStrike
CRWD
|
+$182M |
Sector Composition
| 1 | Technology | 26.33% |
| 2 | Consumer Discretionary | 10.98% |
| 3 | Financials | 10.47% |
| 4 | Healthcare | 8.82% |
| 5 | Communication Services | 7.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
4001
GoHealth
GOCO
$76.9M
| $39.4K | ﹤0.01% |
3,209
-355
| -10% | -$4.36K |
|
4002
Crescent Capital BDC
CCAP
$576M
| $39.1K | ﹤0.01% |
2,285
+185
| +9% | +$3.17K |
|
4003
TScan Therapeutics
TCRX
$99.3M
| $38.8K | ﹤0.01% |
28,146
-12,097
| -30% | -$16.7K |
|
|
AVR
4004
Anteris Technologies
AVR
$189M
| $38.5K | ﹤0.01% |
+10,585
| New | +$38.5K |
|
4005
Angi Inc
ANGI
$808M
| $38.3K | ﹤0.01% |
2,485
+1,868
| +303% | +$28.8K |
|
4006
Betterware México
BWMX
$502M
| $38.3K | ﹤0.01% |
3,365
+862
| +34% | +$9.8K |
|
|
EFXT
4007
Enerflex
EFXT
$1.31B
| $38.3K | ﹤0.01% |
4,952
-1,171
| -19% | -$9.05K |
|
4008
Ramaco Resources Class B
METCB
$1.13B
| $38.1K | ﹤0.01% |
5,359
+534
| +11% | +$3.8K |
|
4009
Vera Bradley
VRA
$57.3M
| $38.1K | ﹤0.01% |
16,927
-2,139
| -11% | -$4.81K |
|
4010
Nuveen Municipal Value Fund
NUV
$1.86B
| $38K | ﹤0.01% |
4,332
+25
| +0.6% | +$219 |
|
4011
Ultralife
ULBI
$115M
| $37.7K | ﹤0.01% |
7,010
-784
| -10% | -$4.22K |
|
|
CLPR
4012
Clipper Realty
CLPR
$68.1M
| $37.6K | ﹤0.01% |
9,794
+206
| +2% | +$791 |
|
4013
Gyre Therapeutics
GYRE
$686M
| $37.5K | ﹤0.01% |
4,853
-546
| -10% | -$4.22K |
|
4014
Ispire Technology
ISPR
$171M
| $37.3K | ﹤0.01% |
13,672
-1,703
| -11% | -$4.65K |
|
4015
Oppenheimer Holdings
OPY
$830M
| $37.3K | ﹤0.01% |
625
+116
| +23% | +$6.92K |
|
4016
Applied Therapeutics
APLT
$64M
| $37.1K | ﹤0.01% |
75,837
-4,008
| -5% | -$1.96K |
|
4017
Kyverna Therapeutics
KYTX
$246M
| $37K | ﹤0.01% |
19,153
-1,172
| -6% | -$2.26K |
|
4018
Gladstone Capital
GLAD
$523M
| $36.6K | ﹤0.01% |
1,334
+99
| +8% | +$2.72K |
|
|
BLUE
4019
DELISTED
bluebird bio
BLUE
| $36.6K | ﹤0.01% |
7,503
-896
| -11% | -$4.37K |
|
4020
Actinium Pharmaceuticals
ATNM
$51.2M
| $36.5K | ﹤0.01% |
22,694
-2,614
| -10% | -$4.21K |
|
4021
LiveOne
LVO
$59.1M
| $36.5K | ﹤0.01% |
52,263
-7,456
| -12% | -$5.21K |
|
4022
CureVac
CVAC
$1.2B
| $36.3K | ﹤0.01% |
13,098
-878
| -6% | -$2.43K |
|
|
SA
4023
Seabridge Gold
SA
$2.04B
| $35.9K | ﹤0.01% |
3,087
+23
| +0.8% | +$268 |
|
|
KG
4024
Kestrel Group
KG
$222M
| $35.7K | ﹤0.01% |
3,128
-876
| -22% | -$9.99K |
|
4025
Forafric Global
AFRI
$243M
| $35.5K | ﹤0.01% |
4,130
-341
| -8% | -$2.93K |
|